Other
Endometrial Polyp
4
Pipeline Programs↗
1
Active Trials↗
3
Companies Involved↗
Endometrial Polyp is an early-stage landscape with 4 programs across 3 companies. The most active players are Pfizer, Ferring, Solvay Pharmaceuticals. 1 therapy is approved with 2 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 1
No programs
Phase 2
No programs
Approved1
Analysis
Trial Status
4
clinical trials
Completed2 · 50%
Unknown status1 · 25%
Not yet recruiting1 · 25%
Clinical Trials
Trial Activity
The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence
Not yet recruiting·—·N/A·NCT06620939·558 enrolled
Misoprostol as a Treatment for Endometrial Polyps in Infertile Patients
Completed·—·Phase 2/3·NCT04270994·54 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)